gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braren, R; Eckstein, HH; Fingerle, A; Laugwitz, KL; Nadjiri, J; Noël, PB; Pfeiffer, D; Rasper, M; Rummeny, EJ; Straeter, AS | 1 |
| Bonnemain, B; Bourrinet, P; Champeroux, P; Drici, M; El Amrani, AI; Fauchou, N; Gaillard, S; Le Coz, F; Martel, E; Richard, S | 1 |
1 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular safety of gadoterate meglumine (Gd-DOTA).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Blood Pressure; Cardiovascular Diseases; Contrast Media; Dogs; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Heart; Heart Rate; Heterocyclic Compounds; Humans; Male; Middle Aged; Organometallic Compounds; Risk Assessment | 2007 |
1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cardiovascular Diseases
| Article | Year |
|---|---|
Spectral Computed Tomography Angiography With a Gadolinium-based Contrast Agent: First Clinical Imaging Results in Cardiovascular Applications.
Topics: Aged; Aortography; Cardiovascular Diseases; Computed Tomography Angiography; Contrast Media; Coronary Angiography; Feasibility Studies; Female; Heterocyclic Compounds; Humans; Male; Organometallic Compounds; Pulmonary Artery; Radiographic Image Enhancement; Reproducibility of Results | 2018 |